Delaware
|
000-23017
|
41-1649949
|
||
(State or other jurisdiction
of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
||
8Penn Center
1628 JFK Blvd., Suite 300
Philadelphia, PA
|
19103
|
|||
(Address of principal executive offices)
|
(Zip Code)
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
1.
|
The election of two Class I directors to the Company’s Board of Directors for a term of three years;
|
2.
|
The approval of an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of Common Stock from 100,000,000 to 150,000,000;
|
3.
|
The approval of an amendment to the Company’s 2008 Equity Incentive Plan (the “2008 Plan”) to increase the maximum number of shares of Common Stock available under the 2008 Plan from 4,700,000 to 10,000,000;
|
4.
|
The approval, on an advisory basis, of the Company’s named executive officer compensation as disclosed in the Company’s proxy statement for the Annual Meeting;
|
5.
|
The approval, on an advisory basis, of the frequency of future advisory executive compensation votes;
|
6.
|
The ratification of the appointment of Wolf & Company, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2012.
|
1.
|
Election of two Class I directors to the Company’s Board of Directors for a term of three years:
|
FOR
|
AGAINST / WITHHELD
|
ABSTENTIONS
|
BROKER
NON-VOTES
|
|||||||||||||
William F. Grieco
|
15,682,545 | 744,783 | — | 15,047,954 | ||||||||||||
James F. Smith
|
15,676,585 | 750,743 | — | 15,047,954 |
2.
|
Approval of an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of Common Stock from 100,000,000 to 150,000,000:
|
FOR
|
AGAINST / WITHHELD
|
ABSTENTIONS
|
BROKER
NON-VOTES
|
|||||||||||
26,562,966 | 3,884,004 | 775,469 | 252,843 |
3.
|
Approval of an amendment to the 2008 Plan to increase the maximum number of shares of Common Stock available under the 2008 Plan from 4,700,000 to 10,000,000:
|
FOR
|
AGAINST / WITHHELD
|
ABSTENTIONS
|
BROKER
NON-VOTES
|
|||||||||||
15,322,603 | 786,919 | 317,806 | 15,047,954 |
4.
|
Approval, on an advisory basis, of the Company’s named executive officer compensation as disclosed in the Company’s proxy statement for the Annual Meeting:
|
FOR
|
AGAINST / WITHHELD
|
ABSTENTIONS
|
BROKER
NON-VOTES
|
|||||||||||
15,721,793 | 359,427 | 346,108 | 15,047,954 |
5.
|
Approval, on an advisory basis, of the frequency of future advisory executive compensation votes:
|
1 YEAR
|
2 YEARS
|
3 YEARS
|
ABSTENTIONS
|
BROKER
NON-VOTES
|
||||||||||||||
1,083,667 | 14,358,043 | 252,298 | 733,320 | 15,047,954 |
6.
|
Ratification of the appointment of Wolf & Company, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2012:
|
FOR
|
AGAINST / WITHHELD
|
ABSTENTIONS
|
BROKER
NON-VOTES
|
|||||||||||
31,226,643 | 135,929 | 112,710 | — |
ECHO THERAPEUTICS, INC.
|
||
Dated: June 22, 2012
|
By: /s/ Patrick T. Mooney
|
|
Patrick T. Mooney
|
||
President and Chief Executive Officer
|
||